Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial

Thumbnail
Name:
Publisher version
Authors
von Haehling, Stephan
Schefold, Joerg C.
Jankowska, Ewa A.
Springer, Jochen
Vazir, Ali
Kalra, Paul R.
Sandek, Anja
Fauler, Günter
Stojakovic, Tatjana
Trauner, Michael
Affiliation
Charité Medical School
Military Hospital, Wroclaw
University of East Anglia
National Heart and Lung Institute
Portsmouth Hospitals NHS Trust
Medical University of Graz
Medical University of Vienna
IRCCS San Raffaele
Issue Date
2012-02-07
Subjects
ursodeoxycholic acid
endothelial function
inflammatory markers
chronic heart failure

Metadata
Show full item record
Abstract
This study sought to assess the effects of ursodeoxycholic acid (UDCA) on endothelial function and inflammatory markers in patients with chronic heart failure (CHF).
Citation
von Haehling, S. et al (2012) 'Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial' J. Am. Coll. Cardiol. 59 (6):585-92
Publisher
American College of Cardiology
Journal
Journal of the American College of Cardiology
URI
http://hdl.handle.net/10547/593510
DOI
10.1016/j.jacc.2011.10.880
PubMed ID
22300693
Additional Links
http://content.onlinejacc.org/article.aspx?articleid=1201106
Type
Article
Language
en
ISSN
1558-3597
Collections